Senior insider sale
Chief Financial Officer at ALPHA TAU MEDICAL LTD. — senior position signals high conviction
$611.5K
57.50K shares
What this filing means
LEVY RAPHI plans to sell 57.50K shares of ALPHA TAU MEDICAL LTD. valued at approximately $611.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001976408-26-000605
Officer· Chief Financial Officer
Since Mar 2026
57.50K
Shares to sell
$611.5K
Approx. market value
65.75K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
4/1/2023
65.75KTotal acquired65.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2023 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 65.75K | — |
| Total | 65.75K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
20K
Market value
$220.0K
6/25/2026
—Completed
Units to sell
17.50K
Market value
$167.1K
6/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$224.4K
6/30/2026
Total
Units
57.50K
Value
$611.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 20K | $220.0K | — | Completed |
6/23/2026 | 17.50K | $167.1K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 20K | $224.4K | NASDAQ | Planned |
| Total | 57.50K | $611.5K | ||